Oncology meetings are critical venues for presentation and discussion of clinical trials that inform and transform the standard of care. For patients with hepatobiliary cancers, immunotherapy-based treatments have ushered a new era of management, with newer approaches being explored along the treatment continuum.

This resource center is built to offer short-form learning focused on updates from recent oncology conferences in the space of unresectable hepatocellular carcinoma and advanced biliary tract cancers. Each activity in this program offers insights into how novel studies refine and inform the current standard of care, with emphasis on improving coordination of care and identifying patients with adverse risk factors who may benefit from immunotherapy-based approaches.